Merck KGaA's U.S. research division is implementing a mandatory three-day-a-week in-office policy for its R&D staff. This new requirement applies to employees previously hired for remote work. Those unwilling to relocate or commute to the Billerica office will face potential layoffs. The company is offering relocation assistance to affected employees. Up to seventy individuals may be impacted by this policy change.
Billerica, Massachusetts
https://www.fiercebiotech.com/biotech/merck-kgaa-institutes-office-requirement-us-research-team-could-lead-70-layoffs